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Background: The Spinal Instability Neoplastic Score (SINS) categorizes tumor related spinal instability. It has the
potential to streamline the referral of patients with established or potential spinal instability to a spine surgeon. This
study aims to define the inter- and intra-observer reliability and validity of SINS among radiation oncologists.
Methods: Thirty-three radiation oncologists, across ten international sites, rated 30 neoplastic spinal disease cases.
For each case, the total SINS (0-18 points), three clinical categories (stable: 0-6 points, potentially unstable: 7-12
points, and unstable: 13-18 points), and a binary scale (‘stable’: 0-6 points and ‘current or possible instability’; surgical
consultation recommended: 7-18 points) were recorded. Evaluation was repeated 6-8 weeks later. Inter-observer
agreement and intra-observer reproducibility were calculated by means of the kappa statistic and translated into
levels of agreement (slight, fair, moderate, substantial, and excellent). Validity was determined by comparing the
ratings against a spinal surgeon’s consensus standard.
Results: Radiation oncologists demonstrated substantial (κ = 0.76) inter-observer and excellent (κ = 0.80) intra-observer
reliability when using the SINS binary scale (‘stable’ versus ‘current or possible instability’). Validity of the binary scale
was also excellent (κ = 0.85) compared with the gold standard. None of the unstable cases was rated as stable by the
radiation oncologists ensuring all were appropriately recommended for surgical consultation.
Conclusions: Among radiation oncologists SINS is a highly reliable, reproducible, and valid assessment tool to address
a key question in tumor related spinal disease: Is the spine ‘stable’ or is there ‘current or possible instability’ that
warrants surgical assessment?
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Spinal column metastases are present in up to 70% of
cancer patients and as life expectancy improves with
advances in oncology treatment, rates are expected to
increase [1-3]. The modalities available to treat patients
with metastatic spine disease continue to evolve and are
offered by a range of healthcare professionals including* Correspondence: charles.fisher@vch.ca
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cialists, and surgeons. The aim of these treatments is
to optimize a patient’s quality of life by providing effect-
ive pain relief and preserving or restoring neurological
function.
Consultation with spine surgeons is typically initiated
when neurological decompression or stabilization of
impending or existing spinal instability is considered
necessary. The Spinal Oncology Study Group (SOSG),
consisting of 30 international spine oncology surgeons,
recently defined spinal instability as “… loss of spinal
integrity as a result of a neoplastic process that is as-
sociated with movement-related pain, symptomatic ortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Table 1 The SINS classification according to Fisher et al. [4]
Score
Location
Junctional (occiput-C2, C7-T2, T11-L1, L5-S1) 3
Mobile spine (C3-C6, L2-L4) 2
Semirigid (T3-T10) 1
Rigid (S2-S5) 0
Pain*
Yes 3
Occasional pain but not mechanical 1
Pain-free lesion 0
Bone lesion
Lytic 2
Mixed (lytic/blastic) 1
Blastic 0
Radiographic spinal alignment
Subluxation/translation present 4
De novo deformity (kyphosis/scoliosis) 2
Normal alignment 0
Vertebral body collapse
> 50% collapse 3
< 50% collapse 2
No collapse with > 50% body involved 1
None of the above 0
Posterolateral involvement of spinal elements†
Bilateral 3
Unilateral 1
None of the above 0
*Pain improvement with recumbency and/or pain with movement/loading
of spine.
†Facet, pedicle, or costovertebral joint fracture or replacement with tumor.
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physiological loads” [4]. Although vitally important, the
assessment of tumor related spinal instability for the
spine surgeon is challenging despite it being part of their
training and practice. Being outside the surgical realm,
instability recognition for the oncologist and other non-
surgical members of the multidisciplinary care team is
probably even more demanding; possibly resulting in
under-recognition and under-referral of patients who
may benefit from surgical intervention [5,6].
Recently, the SOSG developed the Spinal Instability
Neoplastic Score (SINS), a standardized framework to
help physicians assess and categorize spinal instability
[7]. The purpose of SINS is to provide a tool to facilitate
referrals for assessment and possible treatment of in-
stability, a condition that can lead to catastrophic neuro-
logical, deformity and painful situations. The SINS
evaluates spinal stability by adding together six radio-
graphic and clinical components, with a score ranging
from 0 to 18 (Table 1). A clinical example is shown in
Figure 1. The total score is divided in three categories
of stability: stable (0-6 points), potentially unstable
(7-12 points), and unstable (13-18 points). In addition,
the SINS score can also be analyzed as a binary indicator
of surgical referral status: ‘stable’ (0-6 points) or ‘current
or possible instability’ (7-18 points). Surgical consultation
is recommended for those patients with a score of ≥7
(Table 2).
The SINS performance was previously tested among
members of the SOSG. This study revealed a sensitivity
and specificity for potentially unstable or unstable le-
sions of 95.7% and 79.5%, respectively. It demonstrated
near-perfect inter- and intra-observer reliability for dif-
ferentiating the three clinical categories of stability [8].
Patients with spinal metastases receive the majority of
their care from oncologists who often find evaluating
stability difficult. Therefore, before the widespread use
of SINS can be recommended and studied prospectively,
its reliability and validity has to be established among
oncologists. The purpose of this study is to assess the re-
liability and validity of the SINS score among radiation
oncologists. We envision that the SINS can be used in
the future to assist in directing appropriate evaluation
and referral of these complex patients to spine surgeons
when necessary.
Methods
Patient cases
A radiation oncologist and spinal surgeon not related
to or participating in the study compiled 30 de-identified
cases of metastatic spine disease. The cases were com-
prised of 13 females and 17 males, with ages ranging
from 40-79 and were reviewed at ten international sites.
Twelve primary pathologies were represented with lung(n = 6), prostate (n = 6), breast (n = 5), and myeloma (n = 4)
being most popular. Lesions were spread across the cer-
vical (C0-C7) spine (n = 6), thoracic (T1-T10) spine
(n = 11), thoracolumbar (T11-L2) junction (n = 8), and
low lumbar (L3-L5) regions (n = 5). Information provided
included demographic data, histopathological diagnosis,
and relevant clinical information including a pain de-
scription that emphasized the relationship of the pain to
activity and rest; the purpose being to differentiate onco-
logic from mechanical or movement related pain. Plain
radiographs, Computed Tomography (CT) images, and
Magnetic Resonance (MR) images followed. CT scans
were provided for each assessment.
To determine a validity reference or surgical consensus
standard, 11 fellowship trained oncology spine surgeons
from both neurosurgical and orthopedic backgrounds,
all experienced with the SINS classification, rated the
cases once. None of the raters had been involved in the
Figure 1 A 67-year-old man with known metastatic small cell lung cancer presents with interscapular back pain that is exacerbated by
movement and relieved with rest. Computed Tomography (CT) (A: left parasagittal, B: midline parasagittal, C: right parasagittal, D: coronal, and
E: axial) and Magnectic Resonance (MR) images (F: sagittal, T2-weighted) outline the key details of this T5 lesion. Total SINS score = Semirigid (T5)
spine, 1 point; ‘Mechanical’ pain (yes), 3 points; Lytic lesion, 2 points; De novo kyphotic deformity without subluxation/translation, 2 points; >50%
vertebral body collapse, 3 points; and bilateral posterolateral spinal element involvement, 3 points. Total SINS score = 1 + 3 + 2 + 2 + 3 + 3 = 14
(unstable, surgical consultation is recommended).
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was the value that occurred most frequently. In cases
where ties occurred, the two most frequent scores were
averaged to calculate the final value.
After undergoing an instructional session and case
examples on the application of the SINS, 33 radiation
oncologists from North America, Europe, and Asia inde-
pendently scored the SINS on the same 30 cases. Six to
eight weeks later, after the order of cases was changed to
minimize recall bias, the cases were scored again. The
radiation oncologists received a stipend for scoring the
cases. None of the cases in the instructional session were
used in the actual study cases.Table 2 SINS scores organized as a total score, three-clinical c
levels of stability where surgical consultation is recommende
Total Score (0-18 SINS) 1 2 3 4 5 6 7
Three Clinical Categories (3-point) Stability
Binary Scale (2-point) StabilityFor each case, the SINS score was rated and analyzed
as a total (0-18) point score, as three clinical categories
(0-6 points indicating a stable spine, 7-12 points indicating
potentially unstable spine, and 13-18 points indicating an
unstable spine), and as a binary scale (‘stable’ (0-6 points)
or ‘current or possible instability’ (7-18 points)) (Table 2).
This study received ethics committee approval.
Statistical analysis
Inter-observer agreement was calculated for both the
radiation oncologists and the surgeons based on the
first review using the Fleiss’ kappa for multiple raters
[9]. Confidence intervals for the kappa estimates wereategories, and binary scale with their corresponding
d for a total score ≥ 7
8 9 10 11 12 13 14 15 16 17 18
Potentially Unstable Unstable
Current or potential instability;
Surgical consultation recommended
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kappa estimates, and using the 2.5 and 97.5 percentiles
for the confidence intervals. Intra-observer reproducibility
was assessed for the radiation oncologists using the aver-
age Cohen’s kappa [10]. The kappa coefficients (κ) were
calculated for the three clinical categories (3-point scale),
and the binary scale (2-point scale) and interpreted ac-
cording to the widely accepted Landis and Koch [11] grad-
ing system (Table 3). The intraclass correlation coefficient
(ICC) was used to measure both the inter- and intra-
observer agreement for the total point score. As a measure
of validity, the average kappa for agreement between the
radiation oncologists’ rating and the surgeon’s consensus
standard was used. The magnitude of agreement guide-
lines of the kappa, ranging from “no agreement” to
“almost perfect agreement”, was also used (Table 3). All
statistical analyses were performed with Stata 12.0 for
Windows (StataCorp LP, College Station, TX, USA).
Role of the funding source
AOSpine International provided resources necessary to
conduct this study including stipends to the radiation
oncologists who reviewed the cases. They facilitated
strategic project meetings with the co-authors and assisted
in the study management process. The authors were not
compensated.
Results
Inter-observer agreement
Among surgeons, substantial (κ = 0.65) agreement for
the three clinical categories and excellent (κ = 0.83)
agreement for the binary scale was achieved. The agree-
ment among the radiation oncologists for the three clinical
categories and binary scale was moderate (κ = 0.54) and
substantial (κ = 0.76), respectively (Table 4). Inter-observer
agreement of the total point score was ICC = 0.85 among
the surgeons and ICC = 0.80 among radiation oncologists.
Among radiation oncologists, analysis of the separate SINS
components showed excellent level of agreement for loca-
tion (κ = 0.94) and pain (κ = 0.88) and moderate agree-
ment for bone lesion quality (κ = 0.55), spinal alignment
(κ = 0.42), vertebral body collapse (κ = 0.57), and postero-
lateral involvement of the spinal elements (κ = 0.43).Table 3 Levels of agreement for κ statistic levels
κ Value Level of agreement
0.00-0.20 Slight
0.21-0.40 Fair
0.41-0.60 Moderate
0.61-0.80 Substantial
> 0.80 Excellent
NOTE. Data adapted from Landis and Koch [11].Intra-observer reproducibility
Among radiation oncologists, intra-observer reproduci-
bility was substantial (κ = 0.65) for the three clinical cat-
egories and excellent (κ = 0.80) for the binary scale
(Table 4). Intra-observer reproducibility of the total
point score among radiation oncologists was ICC = 0.88.
Analysis of the separate SINS components showed ex-
cellent reproducibility for location (κ = 0.96) and pain
(κ = 0.91), substantial consistency for bone lesion quality
(κ = 0.68), spinal alignment (κ = 0.63), and vertebral body
collapse (κ = 0.63), and moderate agreement for postero-
lateral involvement of the spinal elements (κ = 0.58).
Validity
The level of agreement (average Cohen’s kappa) between
the spine surgeon’s consensus standard and the radiation
oncologists for the three clinical categories was 0.61 and
0.85 for the binary scale. Table 5 outlines the three clin-
ical categories (0-6 stable, 7-12 potentially unstable, and
13-18 unstable) rated by the radiation oncologists cross-
tabulated with the spine surgeons opinion, the gold
standard. None of the unstable cases and only 18 of 561
(3%) of the potentially unstable cases, as determined by
spine surgeon’s consensus standard, was rated as stable
by the radiation oncologists. These potentially unstable
and unstable cases were rated a score (≥7) for which sur-
gical consultation is may be prudent. Fourteen percent
of cases rated stable by the surgeons were considered
potentially unstable by the oncologists.
Discussion
Metastatic spine disease requires a multidisciplinary ap-
proach in order to provide optimal care; therefore, it is
important to establish a clear framework and termin-
ology when describing important parameters such as
spinal stability to avoid variability in interpretation, re-
ferral patterns and consequently patient management.
SINS is a highly reliable, reproducible and provisionally
valid assessment tool for radiation oncologists attempt-
ing to answer a key question in tumor related spinal
disease: Is the spine ‘stable’ or is there ‘current or po-
tential instability’ that warrants surgical assessment?
Based on the current study, we propose that the SINS
should become part of the routine clinical assessment
of patients with symptomatic spinal metastases. Al-
though SINS has not undergone prospective clinical
evaluation, it has been derived through evidence based
medicine methodology and is the closest thing to a gold
standard we have. In development of a classification
or tool such as SINS, it must be assessed for face,
content and criterion validity, along with reliability.
With these established SINS can undergo prospective
validation and only then, if successful, will it be a true
gold standard.
Table 4 Reliability analysis of the SINS among radiation oncologists and spine surgeons
Profession Inter-observer agreement Intra-observer reproducibility
Three-point scale (95% CI) Binary scale (95% CI) Three-point scale (95% CI) Binary scale (95% CI)
Radiation oncologists 0.54 (0.40-0.64) 0.76 (0.56-0.88) 0.65 (0.60-0.71) 0.80 (0.74-0.86)
Spine surgeons (Gold standard) 0.65 (0.50-0.75) 0.83 (0.65-0.93) n.a. n.a.
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SINS score varied between ‘moderate’ and ‘excellent’. In
part, this may be attributable to the study design with
limited information provided for each case compared to
the true clinical situation. Trying to accurately mimic
real practice is one of the inherent limitations of doing
reliability studies and could serve to increase or decrease
reliability. For example, more history would be obtain-
able from ‘real’ patients with respect to movement-
related pain that may strengthen agreement. Conversely,
history taking varies and patients are sometimes vague
and do not have a distinct pain character and this could
increase variability. The authors are hopeful that SINS
will increase awareness of movement related pain and
lead to accurate capture of this important variable. In
the study there was excellent reproducibility on the pain
component (κ = 0.91). Only moderate agreement was
recorded for bone lesion quality, spinal alignment, verte-
bral body collapse, and posterolateral involvement of the
spinal elements. Similar findings were noted when the
reliability of the SINS was tested among members of the
SOSG [8]. We acknowledge that these components may
have a greater degree of subjective interpretation but it
may reflect the availability of appropriate imaging or the
inability to scroll through reformatted images in the
study setting. On the other hand, having representative
images selected for the study could improve reliability.
Similarly in real practice, scrolling through reams of
images to obtain representative ones could lead to in-
creased variability. Imperfect agreement on location may
reflect a discrepancy in application of SINS or illustrate
limitations in anatomical interpretation of the static im-
ages provided. The only way these limitations will be
truly assessed is during prospective evaluation in aTable 5 Cross tabulation of scores determined by the gold
standard and categorization by radiation oncologists
Gold standard Total
Three-point Scale SINS by
Radiation Oncologists
Stable Potentially
unstable
Unstable
Stable 170 18 0 188
Potentially Unstable 28 409 56 493
Unstable 0 134 175 309
Total 198 561 231 990
Gold Standard: score occurred most frequently among spine surgeons.
Radiation oncologist first assessment (N = 30).clinical setting. While agreement between surgeons and
radiation oncologists was favorable for the total (0-18)
point score, this measure is far less clinically relevant
than the binary scale. Finally, the radiation oncologists’
lack of familiarity with some of the terms in SINS may
also impact reliability.
Many scoring systems aiming to select patients that
may benefit from spinal surgery for metastatic disease
exist. Almost all attempt to guide decision-making by
predicting survival prognosis [12-17]. In addition to
prognosis, other key factors require consideration, in-
cluding spinal stability. Spinal metastases can cause
spinal instability, which may present as severe pain,
progressive deformity and/or neurological compromise,
all potential indications for surgical intervention. Prior to
the development of the SINS classification the assess-
ment of spinal integrity lacked standardization and
proved difficult especially for non-surgical members of
the multidisciplinary care team. The goal of the SINS
classification is to provide a framework that helps all
healthcare professionals identify patients with impending
or existing spinal instability who may benefit from surgi-
cal intervention. A SINS score of 7 or greater should
prompt consultation with a spine surgeon, who can high-
light the available surgical options during collabora-
tive discussions on a patient’s optimal treatment. A
potential limitation of this however is too many unneces-
sary referrals, which is likely not economically respon-
sible. Fourteen percent of cases rated stable by the
surgeons were considered potentially unstable by the
radiation oncologists. This must be assessed with SINS’
prospective evaluation in a multicenter clinical setting.
Reliability of the SINS has already been evaluated
among members of the SOSG [8]. Before widespread
clinical implementation the reliability and validity of the
SINS should be investigated across healthcare specialties.
A similar assessment of the SINS classification with
radiologists has also been initiated. SINS may also
prove valuable beyond the clinical setting as a research
tool to better classify patients and as instability is likely a
strong confounder for several outcomes in treatment
evaluation.
Our study showed substantial inter-observer and ex-
cellent intra-observer reliability for the binary SINS scale
(stable versus unstable/potentially unstable) among radi-
ation oncologists. Thirty cases were reviewed twice by
33 radiation oncologists at ten international sites, with
Fisher et al. Radiation Oncology 2014, 9:69 Page 6 of 7
http://www.ro-journal.com/content/9/1/69sufficient power (>94%) [18]. Generalizability was en-
hanced by a multicenter, international group of oncolo-
gists who reviewed cases that represented the established
epidemiological profile of metastatic spine disease. SINS
is designed to be reliable and valid throughout the mobile
spine.
With appropriate diagnostic test parameter testing
completed, steps will be taken to implement SINS inte-
gration into clinical practice so multicenter prospective
evaluation can be carried out. With an evidence based
medicine process to develop SINS, followed by reliability
and validity studies involving the key specialists who will
use it, adoption into clinical practice should be feasible.
Furthermore, it would appear limited training is neces-
sary based on the reliability and validity performance of
SINS amongst radiation oncologists after a brief instruc-
tion and case example tutorial.
Conclusions
The Spinal Instability Neoplastic Score (SINS) is a simple,
reliable, and valid tool to determine metastatic spinal in-
stability and facilitate appropriate surgical referral. This
study has shown that among radiation oncologists, the
SINS binary scale provides a reliable tool for rating tumor-
related spinal instability.
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